Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Cardiology|January 12, 2015
Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease - results from EUROPAJoep van der Leeuw, Rohit M Oemrawsingh, Yolanda van der Graaf, et al.
European Heart Journal|June 7, 2012
From abstract to impact in cardiovascular research: factors predicting publication and citationStephan Winnik, Dimitri A Raptis, Janina H Walker, et al.
International Journal of Cardiology|October 22, 2013
The wealth of nations and the dissemination of cardiovascular researchStephan Winnik, Timo Speer, Dimitri A Raptis, et al.
European Journal of Heart Failure|August 10, 2013
Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering propertiesDaniela Dobre, Jeffrey S Borer, Kim Fox, et al.
Journal of Cardiovascular Computed Tomography|October 10, 2022
Randomized comparison of chest pain evaluation with FFR<sub>CT</sub> or standard care: Factors determining US costsMark A Hlatky, Sam Wilding, Beth Stuart, et al.
European Heart Journal|June 12, 2010
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery diseaseJasper Jan Brugts, Aaron Isaacs, Eric Boersma, et al.
Journal of the American College of Cardiology|May 14, 2021
Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI TrialsLawrence A Leiter, Deepak L Bhatt, Darren K McGuire, et al.
The New England Journal of Medicine|September 3, 2019
Ticagrelor in Patients with Stable Coronary Disease and DiabetesP Gabriel Steg, Deepak L Bhatt, Tabassome Simon, et al.
International Journal of Cardiology|October 21, 2022
External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registryJeremie Abtan, Deepak L Bhatt, Yedid Elbez, et al.
Lancet (London, England)|September 6, 2019
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trialDeepak L Bhatt, Philippe Gabriel Steg, Shamir R Mehta, et al.
Pageof 8